Alex Tarr

Virologist at the University of Nottingham. Researching virus entry pathways and antiviral immunity

[Alex Tarr @AlexWTarr]

Wisteria floribunda agglutinin enhances Zaire ebolavirus entry through interactions at specific N-linked glycosylation sites on the virus glycoprotein complex https://t.co/xHMJn4R75N

[Alex Tarr @AlexWTarr]

Congratulations to Dr Richard Brown at PEI for a great paper on SARS-CoV-2 published today in PNAS https://t.co/nhpDoaJkdW

[Theocharis Tsoleridis @Theo_Tsoleridis]

Our study on the development of a simple low-cost pathway to accurately subtype #HepatitisC in sub-Saharan Africa has just been published in the Journal of Medical Virology. 👇🏽 @PostdocPat @JonathanKBall @AlexWTarr @UoNLifeSci @OneVirology
https://t.co/zCI5IMoU9i

[Theocharis Tsoleridis @Theo_Tsoleridis]

Another preprint from our group! How to easily sub-type the incredibly diverse #HepatitisC #virus with genomes from Sub-Saharan Africa that most commercial assays fail upon. @PostdocPat @JonathanKBall @UoNLifeSci #HCV 👇🏽
https://t.co/Gyui0wLHus

[One Virology @OneVirology]

@nottmhospitals and @UoNLifeSci researchers report rare bifacial weakness with paraesthesias variant of Guillain-Barré syndrome in four cases following ChAdOx1 SARS-CoV-2 vaccine. https://t.co/ZaIlTMXetf Vaccination remains extremely safe and the benefits far outweigh the risks.

[Joe Chappell @Thechappell]

Our Retrospective SARS-2 screening work is now published! Several missed cases, incl one of the first known community transmissions in the UK. Great collaborative effort with @JonathanKBall, @PostdocPat, @Theo_Tsoleridis, @mattloose, #NHS and many more!
https://t.co/hEIkafyDME

[Stephen Griffin @SGriffin_Lab]

Chuffed to have what might sadly be our final chapter on the #HCV p7 channel accepted at @eLife
Huge team effort, many not on twitter, but thanks to those on here @OncoVirus_Leeds @ToshanaFoster @AbiBloy @HarrisLabLeeds @AlexWTarr @Stonehouse_Lab

https://t.co/wQFWkk53YI

[Alex Tarr @AlexWTarr]

@SGriffin_Lab @eLife @OncoVirus_Leeds @ToshanaFoster @AbiBloy @HarrisLabLeeds @Stonehouse_Lab Congrats Steve, it's been great to work with you on this project! Hopefully not the end of the HCV work 🙄

[Alex Tarr @AlexWTarr]

Yes, unexpectedly found myself working on a serology study on SARS-CoV-2! Pseudotypes with @rich_urbanowicz, we're rushing to get this completed and submitted...

[Alex Tarr @AlexWTarr]

Congrats to all involved, this is a really interesting study and a great resource for the HCV research community

[Alex Tarr @AlexWTarr]

@PostdocPat @paddy_tighe5 I'm glad Robot Al is doing all the work for me!

[Alex Tarr @AlexWTarr]

High throughput #Covid19 #serology with @paddy_tighe5 and his #robot_army.

[Alex Tarr @AlexWTarr]

Great to be involved in the recruitment for the @UniofOxford #Chadox #Covid19 #Vaccine trial.

[One Virology @OneVirology]

Congratulations to the @UoNLifeSci team for today completing antibody testing for recruitment to the #covid19 #vaccine trial @AlexWTarr @paddy_tighe5 #Neiloldfield #davidturner @NottmBRC @UoNresearch @UoNPressOffice

[NottmBRCLiver&GI @NottmBRCLiverGI]

New paper published in Journal of Clinical Virology 'Nanopore sequencing from extraction-free direct PCR of dried serum spots for portable hepatitis B virus drug-resistance typing' https://t.co/RQFQeKNzdc @stuartastbury @AlexWTarr

[Patrick McClure @PostdocPat]

A project we started back in 2016, before extraction-free amplification was all the rage! 'Nanopore sequencing from extraction-free direct PCR of dried serum spots for portable hepatitis B virus drug-resistance typing'
https://t.co/VqDixlch0v

[One Virology @OneVirology]

Latest research just published by the @UoNLifeSci @UoNresearch virology group on human bocavirus infections.

[One Virology @OneVirology]

A small milestone reached in #Covid_19 @UoNresearch today - 600th #Nottingham sample prepared for antibody testing by @AlexWTarr and #PaddyTighe at @UoNLifeSci virology labs.

[Hits Radio News | East Midlands @HitsEastMidsX]

Health officials say a third UK case of #coronavirus has been confirmed in a patient who caught it in an Asian country other than China.

The person's being treated in a specialist unit.

Jonathan Ball is Professor of emerging viruses at The University of #Nottingham:

[ViralPseudotypeUnit @ViralPseudotype]

Barney King from @OneVirology @UniNottinghamIC telling us about 'hard to pseudotype' viruses with #HepatitisC as as a model. Even clones within same patient behave differently!

[Alex Tarr @AlexWTarr]

@GroveLab @VirologyBochum I think JB's on it :)

[Alex Tarr @AlexWTarr]

This about as current as it gets: Pseudotypes used to assess cell entry of 2019-nCoV via ACE2 https://t.co/bGycnLqSQs